Centre for Amyloidosis and Acute Phase Proteins
Centre for Amyloidosis and Acute Phase Proteins

Medicine News

Lilly Scientific Achievement Award 2014 to Rachel Batterham

Published: Nov 20, 2014 9:40:05 AM

Sheila Sherlock Updates 4-6 December 2014

Published: Nov 17, 2014 11:14:07 AM

The good, the bad and the ugly: Bugs in the gut

Published: Nov 17, 2014 8:18:03 AM

Patents

  1. Screening assays to identify therapeutic agents for amyloidosis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and T.L. Blundell). US Patent No. 6,126,918, granted 3 October 2000.
  2. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,045,499, granted 16 May 2006.
  3. Therapeutic agent for depletion of an unwanted protein population from plasma. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 418 905, granted 2 May 2007.
  4. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). UK Patent No. 2 420 498, granted 28 November 2007.
  5. Therapeutic and diagnostic agents for amyloidosis. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 0 714 405, granted 26 March 2008.
  6. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,390,795, granted 24 June 2008.
  7. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Australian Patent No. 2003234000, granted 18 September 2008.
  8. Treatment and prevention of tissue damage associated with increased C-reactive protein production. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 503 800, granted 28 October 2009.
  9. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,615,543, granted 10 November 2009.
  10. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). US Patent No. 7,659,299, granted 9 February 2010.
  11. Therapeutic agent for depletion of an unwanted protein population from plasma. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Japanese Patent No. 4472333, granted 12 March 2010.
  12. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). Australian Patent No. 2004244815, granted 25 March 2010.
  13. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,691,897, granted 6 April 2010.
  14. Combinations of SAP depleting agents and anti-SAP antibodies. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,910,106, granted 22 March 2011.
  15. Therapeutic agent for depletion of an unwanted protein population from plasma. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 820 501, granted 14 September 2011.
  16. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). European Patent No. 1 633 345, granted 21 September 2011.
  17. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 8,039,222, granted 18 October 2011.
  18. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Canadian Patent No. 2 485 852, granted 17 January 2012.
  19. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 8,173,694, granted 8 May 2012.
  20. Combinations of SAP depleting agents and anti-SAP antibodies. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Singapore Patent No. 157506A, granted 31 May 2012.
  21. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). Canadian Patent No. 2 528 706, granted 30 October 2012.
  22. Combinations of SAP depleting agents and anti-SAP antibodies. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Australian Patent No. 2008267148, granted 25 September 2014.

Page last modified on 17 nov 14 16:11 by E A (Beth) Jones